Avanos Medical, Inc. (AVNS) Misses Q2 EPS by 2c

Avanos Medical, Inc. (NYSE: AVNS) reported Q2 EPS of $0.21, $0.02 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $186 million versus the consensus estimate of $180.56 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2021 EPS of $1.10-$1.20, versus the consensus of $1.21.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c